Cite
APA Citation
Mohammed, S., Mattia, M. A., Gergely, G. K., Gaia, G. S., Ambrosini, S. A., Paolo, P. M., Thomas F, T. F. L., Sarah, S. C., Gian Paolo, G. P. F., & Francesco, F. P. (n.d.). the BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1. European heart journal, 42, . http://access.bl.uk/ark:/81055/vdc_100144252457.0x00002b